TipRanks
Go Ultimate55% OFF

Michael Exton Insider Profile

4 Followers

Michael Exton, CEO, Director at Lexicon Pharmaceuticals, holds 298.43K shares in Lexicon Pharmaceuticals (Ticker: LXRX).

Michael Exton's Trading History

LXRX
Lexicon Pharmaceuticals
Mar 03, 2026CEO, DirectorUninformative Buy438.70K$423.77K
LXRX
Insider Shares: 298.43K (0.08%)

Michael Exton has not reported any informative transactions for LXRX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 03, 2026Uninformative Buy$438.70K298,432$1.47―

You May Also Like

Michael Exton insider profile FAQ

What stocks does Michael Exton hold?
Michael Exton holds: LXRX stocks.
What was Michael Exton’s latest transaction?
Michael Exton’s latest transaction was an Uninformative Buy of $438.70K.
What is Michael Exton's role in Lexicon Pharmaceuticals?
Michael Exton's role in Lexicon Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.